Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population (Q43918662)
Jump to navigation
Jump to search
scientific article published on 12 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population |
scientific article published on 12 December 2012 |
Statements
1 reference
Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population (English)
1 reference
Soffia Gudbjörnsdottir
1 reference
Mervete Miftaraj
1 reference
Swedish National Diabetes Register
1 reference
Ann-Marie Svensson
1 reference
Björn Eliasson
1 reference
Henrik Hadimeri
1 reference
Hanri Afghahi
1 reference
Maria K Svensson
1 reference
12 December 2012
1 reference
1 reference
Identifiers
1 reference